April 28, 2021

OmniSeq receives New York state approval for OmniSeq INSIGHT genomic and immune profiling test

BUFFALO, N.Y., April 28, 2021 - OmniSeq®, an innovator in next generation sequencing in oncology, today announced the New York State Department of Health's Clinical Laboratory Evaluation Program has approved the OmniSeq INSIGHTSM  test. The test detects genomic variants, genomic signatures, and immune gene expression, providing physicians with clinically actionable evidence to inform therapeutic treatment decisions and identify potential clinical trial options for patients with late-stage solid tumor cancers.
Read more »
April 22, 2021

Labcorp opens automated clinical trial kit production line at new European operations center

BURLINGTON, N.C., April 22, 2021 — Labcorp® (NYSE: LH), a leading global life sciences company, today announced the opening of an automated clinical trial kit production line in Mechelen, Belgium, which doubles the automated production capacity of the company’s industry-leading central laboratory services unit. The central laboratory services unit is part of Labcorp’s Drug Development business, also known as Covance by Labcorp.
Read more »

Labcorp Opens Automated Clinical Trial Kit Production Line at New European Operations Center

In Pursuit of Answers

We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—because we know that knowledge has the potential to make life better for all.

We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—because we know that knowledge has the potential to make life better for all.